Yahoo
NSE - Delayed Quote INR

Torrent Pharmaceuticals Limited (TORNTPHARM.NS)

4,595.00 -18.40 (-0.40%)
At close: 3:29:30 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
Name Title Pay Exercised Year Born
Mr. Aman Mehta
MD & Whole-Time Director 188.18M -- --
Mr. Sudhir Menon CA, CWA
Executive Director of Finance & CFO 16.3M -- 1972
Mr. Ashish Hajarnish M.Pharm
Executive Director of Operations -- -- 1968
Ms. Geena V. Malhotra
Chief Technology Officer -- -- --
Mr. Chintan M. Trivedi
Company Secretary & Compliance Officer -- -- --
Mr. Abdullah Salam Said Al Abri
Chief Customer Service Officer -- -- --
Mr. Sanjay Gupta
President and CEO of Torrent Pharma USA -- -- --

Torrent Pharmaceuticals Limited

Avirat, Thaltej Shilaj Road
Ahmedabad, 380059
India
91 79 2659 9000 https://www.torrentpharma.com
Sector: 
Healthcare
Full Time Employees: 
18,258

Description

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Corporate Governance

Torrent Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 23, 2026 at 10:00 AM UTC

Torrent Pharmaceuticals Limited Earnings Date

Recent Events

May 29, 2026 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: